Sign up to our newsletter Subscribe
Willingness-to-Pay for a New Pharmaceutical: Is it Worth the Money? Whose Money? During this OHE Lunchtime Seminar, Prof Peter Zweifel, University of Zurich, will discuss the findings from a discrete-choice experiment conducted in Germany to elicit the willingness to pay for modern insulin…
Willingness-to-Pay for a New Pharmaceutical: Is it Worth the Money? Whose Money?
During this OHE Lunchtime Seminar, Prof Peter Zweifel, University of Zurich, will discuss the findings from a discrete-choice experiment conducted in Germany to elicit the willingness to pay for modern insulin therapy using a long-acting insulin analogue rather than conventional insulin. Choice experiments such as this could pave the way for actually applying the cost-benefit standard to health care. For more details, see our earlier post.
The seminar will be held 12.00-2.00 PM, Friday, 16 July, at the OHE, 12 Whitehall, London. Space is limited at this seminar.
An error has occurred, please try again later.
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.
This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.
Keeping this cookie enabled helps us to improve our website.
Please enable Strictly Necessary Cookies first so that we can save your preferences!
